Chronic fatigue syndrome

4.12.2018

Question for written answer E-006124-18
to the Commission
Rule 130
Mairead McGuinness (PPE)

Myalgic encephalomyelitis (ME), or chronic fatigue syndrome (CFS), is a severe disease affecting more than one million people in the European Union, 80% of whom are women.

New research shows that ‘phenylalanine can be used as a potential biomarker for the diagnosis of CFS’[1] .

This is a blood-based diagnostic test for ME/CFS.

Is the Commission aware of this new research?

Will it make funding available for the research and development of diagnostic tests for ME/CFS?

• [1] https://pubs.rsc.org/en/content/articlelanding/2018/an/c8an01437j#!divAbstract